Jim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses'

Why is Procter & Gamble cutting 7,000 jobs? How is the Trump-Musk feud affecting Tesla's stock? What caused Circle's stock to surge after IPO? Why did Elon Musk threaten to decommission SpaceX Dragon? How are Trump's tariffs impacting U.S. companies? What are the implications of Trump's new travel ban? Why did Lululemon slash its profit forecast?

Jim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses'

benzinga.com/analyst-stock-ratings/analyst-color/25/06/45767953/jim-cramer-arrowhead-pharmaceuticals-doesnt-have-the-horses

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Dover Corporation (NYSE:DOV).
Supporting his view, Dover, on April 24, posted better-than-expected earnings for the first quarter.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) doesn’t make any money, Cramer said. “I…

This story appeared on benzinga.com, 2025-06-04 12:02:37.